SG Americas Securities LLC Purchases New Shares in Amprius Technologies, Inc. $AMPX

Key Points

• SG Americas Securities LLC acquired a new stake of 255,252 shares of Amprius (NYSE:AMPX) in Q4, valued at about $2.01 million and representing roughly 0.20% of the company.
• Insiders sold a total of 4,647,226 shares worth $65.74 million in the last three months, including Director Kang Sun’s sale of 1.5 million shares at $15.91.
• Analyst sentiment is mostly positive with a consensus "Moderate Buy" and an average price target of $19.75 (several firms raised targets to $20–$21); Amprius recently beat quarterly estimates (EPS -$0.01 vs. -$0.04, revenue $25.23M vs. $22.91M) but remains unprofitable.

SG Americas Securities LLC acquired a new stake in Amprius Technologies, Inc. (NYSE:AMPX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 255,252 shares of the company's stock, valued at approximately $2,014,000. SG Americas Securities LLC owned about 0.20% of Amprius Technologies as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Quarry LP acquired a new stake in shares of Amprius Technologies in the third quarter valued at $42,000. Jones Financial Companies Lllp lifted its position in Amprius Technologies by 353.2% during the 3rd quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company's stock worth $50,000 after buying an additional 3,532 shares in the last quarter. Parallel Advisors LLC acquired a new position in Amprius Technologies during the 3rd quarter worth about $54,000. Geneos Wealth Management Inc. bought a new stake in Amprius Technologies during the 3rd quarter worth about $74,000. Finally, Cambridge Financial Group LLC bought a new stake in Amprius Technologies during the 4th quarter worth about $78,000. Institutional investors and hedge funds own 5.04% of the company's stock.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, Director Kang Sun sold 1,500,000 shares of Amprius Technologies stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total transaction of $23,865,000.00. Following the completion of the sale, the director owned 1,342,400 shares of the company's stock, valued at approximately $21,357,584. The trade was a 52.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven Chu sold 166,632 shares of the company's stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $17.92, for a total transaction of $2,986,045.44. Following the sale, the director owned 127,339 shares of the company's stock, valued at $2,281,914.88. The trade was a 56.68% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 4,647,226 shares of company stock valued at $65,744,047 in the last three months. Insiders own 12.90% of the company's stock.

Amprius Technologies Trading Up 0.0%

Shares of NYSE:AMPX opened at $16.01 on Monday. Amprius Technologies, Inc. has a 1-year low of $1.97 and a 1-year high of $19.76. The stock has a market capitalization of $2.19 billion, a P/E ratio of -47.08 and a beta of 2.20. The business has a 50-day moving average price of $14.02 and a two-hundred day moving average price of $12.14.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. The company had revenue of $25.23 million for the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. As a group, equities analysts predict that Amprius Technologies, Inc. will post -0.45 EPS for the current year.

Analysts Set New Price Targets

AMPX has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a "buy" rating and issued a $20.00 target price on shares of Amprius Technologies in a research note on Tuesday, March 10th. Cantor Fitzgerald increased their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a research note on Friday, March 6th. Craig Hallum raised their price target on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a report on Friday, March 6th. Oppenheimer restated an "outperform" rating and issued a $17.00 price objective on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, Amprius Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $19.75.

Amprius Technologies Company Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.